Table 8 Survival time of patients with CD117+ and CD117− GISTs
From: Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
Number of samples | Survival time (average, range) | P-value(log-rank test) | |
|---|---|---|---|
CD117(−) | 3 | 58 (12+–84+ months) | |
CD117(+) | 17 | 52 (2–101+ months) | |
CD117(++) | 23 | 49 (5+–97+ months) | CD117++ and CD117+++: 0.367 |
CD117(+++) | 21 | 24 (8+–97+ months) |
